Psychedelic Policy & Law in 2022 By admin - February 21, 2023 44 Source RELATED ARTICLESMORE FROM AUTHOR Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL) Psychedelic Researchers Respond to FDA’s Push to Reduce Animal Testing
